Dr Reddys Laboratories Ltd Share Price Today - Live Blog for March 10, 2026

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 2.11%, with its current market value per share resting at 1314.10. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's share price has experienced a notable 2.11% upswing, and it's currently trading at 1314.10 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd observed a remarkable 2.17% surge in its share price and is presently trading at 1314.90. The increased investor interest is driving this surge.

Following a noteworthy 2.17% increase, Dr Reddys Laboratories Ltd's shares are now trading at 1314.90. When it comes to valuation, this stock has a PE ratio of 19.4400, with the industry PE ratio at 32.3621.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 2.72% gain, with the share price now at 1322.00. Notably, the stock's PE ratio stands at 19.4400, and its Return on Equity (ROE) is 16.0277.

Dr Reddys Laboratories Ltd's stock has surged by 2.72%, and it is currently trading at 1322.00. Additionally, the stock maintains a PE ratio of 19.4400, while the industry PE is 32.3621.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 2.51%. At this moment, it's actively trading at 1319.30, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd's share price has experienced a notable 2.51% upswing, and it's currently trading at 1319.30 per share. Investors are closely watching this development.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 2.28%, with its current market value per share resting at 1316.40. This development highlights the stock's appeal to investors.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 2.28% recently. As of now, this stock is actively trading at a current market price of 1316.40 per share, attracting attention from investors.

After a notable 2.29% increase, Dr Reddys Laboratories Ltd's shares are now trading at 1316.50. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277.

Dr Reddys Laboratories Ltd's share price rallied by 2.29%, reaching the current market price of 1316.50. This surge is indicative of the stock's recent positive performance.